Elevation Oncology, Inc. (ELEV) NASDAQ
$0.63 0.02 (3.64%)
Market Cap: $37.37M
As of 09/13/24 10:09 AM EDT. Market open.
Elevation Oncology, Inc. (ELEV)
NASDAQ
$0.63
0.02 (3.64%)
Market Cap: $37.37M
As of 09/13/24 10:09 AM EDT. Market open.
Add to Portfolio
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Joseph J. Ferra Jr.
Full Time Employees
29
CEO Compensation (Base)
$590,302
CEO Compensation (Total)
$1.24M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Joseph J. Ferra Jr.
Full Time Employees
29
CEO Compensation (Base)
$590,302
CEO Compensation (Total)
$1.24M
Address
888 Seventh Avenue, NY, New York, 10106.
PRICE CHART FOR ELEVATION ONCOLOGY, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.63
Previous Close
$0.61
Days Range
$0.62 - $0.64
52 week range
$0.36 - $5.83
Volume
34,344
Avg. Volume (30 days)
1,344,237
Market Cap
$37.37M
Dividend Yield
-
P/E
(0.93)
Shares Outstanding
59,106,800
Open
$0.63
Previous Close
$0.61
Days Range
$0.62 - $0.64
52 week range
$0.36 - $5.83
Volume
34,344
Avg. Volume (30 days)
1,344,237
Market Cap
$37.37M
Dividend Yield
-
P/E
(0.93)
Shares Outstanding
59,106,800
FINANCIAL STATEMENTS FOR ELEVATION ONCOLOGY, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ELEVATION ONCOLOGY, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | Aug 15, 2024 | Option Exercise | $0.72 | 89 | 64 | 1,208 | Aug 19, 2024, 04:15 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Jun 16, 2024 | Option Exercise | $3.23 | 4,628 | 14,948 | 93,614 | Jun 18, 2024, 04:15 PM |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | May 15, 2024 | Option Exercise | $3.73 | 100 | 373 | 997 | May 17, 2024, 04:10 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Mar 16, 2024 | Option Exercise | $4.39 | 4,773 | 20,953 | 85,680 | Mar 19, 2024, 04:10 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Dec 16, 2023 | Option Exercise | $0.51 | 4,773 | 2,434 | 77,891 | Dec 19, 2023, 04:15 PM |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | Sep 16, 2023 | Option Exercise | $0.73 | 4,773 | 3,475 | 70,101 | Sep 19, 2023, 04:15 PM |
| Ferra Joseph J Jr | INTERIM CEO & CFO | Jun 16, 2023 | Option Exercise | $1.47 | 4,773 | 7,016 | 62,312 | Jun 21, 2023, 04:06 PM |
| Ferra Joseph J Jr | INTERIM CEO & CFO | Mar 16, 2023 | Option Exercise | $2.35 | 4,773 | 11,217 | 54,522 | Mar 20, 2023, 04:21 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Sep 16, 2022 | Option Exercise | $1.25 | 4,773 | 5,966 | 38,943 | Dec 19, 2022, 07:40 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Jun 16, 2022 | Option Exercise | $1.26 | 19,095 | 24,060 | 31,154 | Dec 19, 2022, 07:40 PM |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | Dec 16, 2022 | Option Exercise | $0.95 | 4,773 | 4,534 | 46,732 | Dec 19, 2022, 07:40 PM |
| venBio Global Strategic Fund III, L.P. | 10% Owner | May 25, 2022 | Sale | $4.12 | 702,737 | 2,897,806 | 1,905,430 | May 27, 2022, 07:20 PM |
| Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 312,500 | 5,000,000 | 2,370,142 | Jul 01, 2021, 07:45 PM |
| Aisling Capital IV, LP | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 187,500 | 3,000,000 | 2,834,910 | Jul 01, 2021, 06:29 PM |
| venBio Global Strategic Fund III, L.P. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 625,000 | 10,000,000 | 2,608,167 | Jul 01, 2021, 05:27 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Jun 29, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 2,233,168 | Jul 01, 2021, 04:24 PM |
| Vertex Global HC Fund II Pte. Ltd. | 10% Owner | Jun 29, 2021 | Buy | $16.00 | 250,000 | 4,000,000 | 2,307,642 | Jun 29, 2021, 04:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | 08/15/2024 | 64 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 06/16/2024 | 14,948 |
| Furlong Tammy | CHIEF FINANCIAL OFFICER | 05/15/2024 | 373 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 03/16/2024 | 20,953 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 12/16/2023 | 2,434 |
| Ferra Joseph J Jr | CHIEF EXECUTIVE OFFICER | 09/16/2023 | 3,475 |
| Ferra Joseph J Jr | INTERIM CEO & CFO | 06/16/2023 | 7,016 |
| Ferra Joseph J Jr | INTERIM CEO & CFO | 03/16/2023 | 11,217 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 09/16/2022 | 5,966 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 06/16/2022 | 24,060 |
| Ferra Joseph J Jr | CHIEF FINANCIAL OFFICER | 12/16/2022 | 4,534 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 05/25/2022 | 2,897,806 |
| Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | 06/29/2021 | 5,000,000 |
| Aisling Capital IV, LP | 10% Owner | 06/29/2021 | 3,000,000 |
| venBio Global Strategic Fund III, L.P. | 10% Owner | 06/29/2021 | 10,000,000 |
| Cormorant Asset Management, LP | Former 10% Owner | 06/29/2021 | 4,000,000 |
| Vertex Global HC Fund II Pte. Ltd. | 10% Owner | 06/29/2021 | 4,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ELEVATION ONCOLOGY, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 3,598,418 | 0.05% | -7.42% | Event Driven, Value |
| BALYASNY ASSET MANAGEMENT L.P. | 2,483,645 | 0.01% | -18.72% | Event Driven |
| BLACKROCK INC. | 2,490,249 | 0.00015% | 1348.65% | Other |
| PALO ALTO INVESTORS LP | 1,800,106 | 0.56% | 33.67% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,031,576 | 0.00024% | 196.06% | Other |
| ORBIMED ADVISORS LLC | 941,275 | 0.05% | No change | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 50,103 | 0.02% | New | Event Driven |
BUYBACK ANNOUNCEMENT(S) FOR ELEVATION ONCOLOGY, INC.
LOADING...